Over a century ago, an influenza epidemic caused widespread parkinsonism; t
hus, it seems ironic th at viral vectors mig ht provide a new therapy for p
atients with Parkinson's disease (PD). However, a recent study presents a s
eries of elegant experiments that demonstrate the restorative and protectiv
e effects of a glial cell line-derived neurotrophic factor (GDNF), delivere
d by lentiviral vectors, in the brains of both old and parkinsonian primate
s. These techniques might hold promise for PD and of her neurodegenerative
disorders.